Packard; Garrick K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Packard; Garrick K..The latest application filed is for "pyrazino[2,3-b]pyrazine mtor kinase inhibitors for oncology indications and diseases associated with the mtor/pi3k/akt pathway".

Company Profile

5.8.9

Packard; Garrick K. - Humbird WI
Packard; Garrick K. - San Diego CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Grant 11,292,796 - Elsner , et al. April 5, 2	2022-04-05
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20200262840 - ELSNER; Jan ; et al.	2020-08-20
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Grant 10,683,298 - Elsner , et al.	2020-06-16
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20190077806 - ELSNER; Jan ; et al.	2019-03-14
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Grant 10,167,290 - Elsner , et al. J	2019-01-01
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20170342080 - ELSNER; Jan ; et al.	2017-11-30
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Grant 9,771,371 - Elsner , et al. September 26, 2	2017-09-26
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20160024101 - ELSNER; Jan ; et al.	2016-01-28
Methods of treatment comprising the administration of heteroaryl compounds Grant 8,372,976 - Mortensen , et al. February 12, 2	2013-02-12
Methods Of Treatment Comprising The Administration Of Heteroaryl Compounds App 20110245245 - Mortensen; Deborah Sue ; et al.	2011-10-06
Heteroaryl compounds, compositions thereof, and methods of treatment therewith Grant 7,981,893 - Mortensen , et al. July 19, 2	2011-07-19
Heteroaryl compounds, compositions thereof, and methods of treatment therewith App 20090023724 - Mortensen; Deborah Sue ; et al.	2009-01-22
Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith App 20080004271 - McKenna; Jeffrey M. ; et al.	2008-01-03
Kinase inhibitors Grant 6,831,175 - Li , et al. December 14, 2	2004-12-14
Kinase inhibitors App 20030199511 - Li, Qun ; et al.	2003-10-23
Kinase inhibitors App 20030187026 - Li, Qun ; et al.	2003-10-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.